-0.24 | -2.70%
| Price and Volume | |
|---|---|
| Recent Price | 8.70 |
| 52 Week High | 12.16 |
| 52 Week Low | 7.12 |
| Avg. Daily Vol. (Mil) | 0.04 |
| Beta (3 year) | 0.07 |
| Share Related Items | |
| Mkt Cap (Mil) | 459.97 |
| Shares Out (Mil) | 52.87 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.10 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.45 |
| Valuation Ratios | |
| Price Earnings | 16.90 |
| Price/Sales | 1.40 |
| Price/Book | 1.41 |
| Price/Cash Flow | 9.70 |
| Per Share Data | |
| Earnings | 0.51 |
| Sales | 6.21 |
| Book Value | 6.15 |
| Cash Flow | 0.89 |
| Business Summary | |
|---|---|
| Simcere Pharmaceutical Group is engaged in the research, development, manufacture and distribution of pharmaceutical products in the People's Republic of China. | |
| General Information | |
| No. 698-18 Xuan Wu Avenue
Xuan Wu District Nanjing, Ji 210042 |
|
| 1.0 | |
| www.simcere.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 4334 | |
| CEO: Jinsheng Ren | |
| Short Interest | |
| Current Month (Mil) | 0.08 |
| Previous Month (Mil) | 0.13 |
| Short Interest Ratio (Days) | 2.20 |
| Management Effectiveness | |
| Return on Equity | 8.70 |
| Return on Assets | 4.90 |
| Return on Investments | 8.70 |
| Profitability | |
| Gross Margin | 83.60 |
| EBIT Margin | 2.40 |
| Profit Margin | 8.60 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,433.86 | 1,315.78 | 2,842.46 | 16.25 |
Oil *
103.14
|
|
DOWN
146.83 |
DOWN
16.64 |
DOWN
28.53 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.93
|
|
-1.17%
|
-1.25%
|
-0.99%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet